Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy

NCT ID: NCT02238730

Last Updated: 2017-02-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2017-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the equivalent efficacy of ultrabrief pulsewidth right unilateral electroconvulsive therapy versus bitemporal brief pulse electroconvulsive therapy in the treatment of depression and to evaluate the cognitive effects of ultrabrief right unilateral electroconvulsive therapy versus bitemporal brief pulse electroconvulsive therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be randomized to either bitemporal brief pulse electroconvulsive therapy ( 0.5 ms pulse width) or right unilateral ultrabrief pulse electroconvulsive therapy for the first six treatments. If further treatment is necessary, electrode placement will be chosen by the treating psychiatrist. All electroconvulsive therapy treatments will be performed with a Thymatron System IV instrument. (Somatics, LLC, Lake Bluff, Illinois, USA) Pre- electroconvulsive therapy testing will occur within one week of beginning treatment. Post-electroconvulsive therapy testing will occur within 48 hours of the 6th treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Depressive Disorder Treatment Resistant Depressive Disorder Bipolar Disorder Major Depressive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ultrabrief Right Unilateral

Ultrabrief (0.25 ms) Right Unilateral Electroconvulsive Therapy

Group Type ACTIVE_COMPARATOR

Ultrabrief Right Unilateral

Intervention Type DEVICE

The first six electroconvulsive therapy sessions using ultrabrief (0.25 ms) right unilateral electroconvulsive therapy

Brief Pulse Bitemporal

Brief Pulse (0.5 ms) Bitemporal Electroconvulsive Therapy

Group Type ACTIVE_COMPARATOR

Brief Pulse Bitemporal

Intervention Type DEVICE

The first six electroconvulsive therapy sessions using brief pulse (0.5 ms) bitemporal electroconvulsive therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrabrief Right Unilateral

The first six electroconvulsive therapy sessions using ultrabrief (0.25 ms) right unilateral electroconvulsive therapy

Intervention Type DEVICE

Brief Pulse Bitemporal

The first six electroconvulsive therapy sessions using brief pulse (0.5 ms) bitemporal electroconvulsive therapy

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Thymatron System IV Thymatron System IV

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients age 18 and above referred for electroconvulsive therapy will be screened for eligibility for participation in this study.
* Basic competency in English
* Diagnosis of either of the following:

1. Major Depressive Disorder, Single Episode
2. Major Depressive Disorder, Recurrent
3. Bipolar Disorder, Currently Depressed

Exclusion Criteria

* Pre-existing cognitive impairment with an initial Mini Mental Status Exam Score of 24 or lower
* Major neurological disease
* Other medical conditions making electroconvulsive therapy an excessive risk to be completed safely in an outpatient surgery center and anticonvulsant therapy.
* Pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaiser Permanente

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ronad L Warnell, MD

Role: PRINCIPAL_INVESTIGATOR

Kaiser Permanente

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KPSC IRB 10133

Identifier Type: OTHER

Identifier Source: secondary_id

KPSC IRB10133

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The RAFT ECT Study
NCT05402657 RECRUITING NA
Neuronavigated TBS in Depression
NCT03953521 TERMINATED NA